AIG
ALGS icon

American International Group’s Aligos Therapeutics ALGS Stock Holding History

American International Group’s Portfolio ALGS Stock Details ALGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-419
Closed -$23K – 3090
2022
Q1 		$23K Sell
419
-30
-7% -$2.4K ﹤0.01% 3006
2021
Q4 		$133K Sell
449
-13
-3% -$4.74K ﹤0.01% 2598
2021
Q3 		$179K Buy
462
+41
+10% +$16.2K ﹤0.01% 2491
2021
Q2 		$214 Buy
421
+177
+73% +$113K ﹤0.01% 2463
2021
Q1 		$139 Buy
244
+9
+4% +$5.99K ﹤0.01% 2547
2020
Q4 		$162 Buy
+235
New +$114K ﹤0.01% 2385

Other funds holding ALGS

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

American International Group's ALGS Position: Q2 2022 in Review

American International Group sold out of Aligos Therapeutics (ALGS) in Q2 2022, closing a stake of 419 shares — an estimated $23K sold.

American International Group first reported a position in ALGS in Q4 2020 and held it in 6 quarters. The position peaked at $179K in Q3 2021. 59 funds tracked by Wall St. Rank hold ALGS as of Q2 2022.

  • American International Group reported no remaining Aligos Therapeutics position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 419 Aligos Therapeutics shares in Q2 2022, an estimated $23K.
  • American International Group first reported a position in Aligos Therapeutics in Q4 2020 and held it in 6 quarters.
  • American International Group's Aligos Therapeutics position peaked at $179K in Q3 2021.
  • 59 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.